Occidental Petroleum Aktie News

Bought 221,760 shares of OXY; estimated transaction value of $10.31 million Trade represents 7.37% of 13F reportable assets under management Post-trade holding: 221,760 shares valued at $10.31 million New OXY stake represents 7.37% of total 13F AUM, placing it outside the fund's top five holdings

When the federal government shuts down, roughly a quarter of the U.S. economy stops with it. So far, investors have remained largely confident that a compromise will be reached.

Buffett's acquisition of OxyChem is a model for how to invest when the market as a whole is expensive. The core of his approach is to buy absolute value and ignore market opinions. The context for Buffett was likely the decline in yield on T-bills, making the purchase of a conservative stock more attractive.

For more than 60 years, Warren Buffett has delivered fortune-creating gains for Berkshire Hathaway's shareowners. While the renowned stock picker intends to step down as CEO of the investment juggernaut he helped build at the end of the year, it's not too late to profit from Buffett's best ideas.

HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its third quarter 2025 financial results after close of market on Monday, November 10, 2025, and will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central.

Occidental Petroleum's $9.7 billion sale of OxyChem was punished by the market for several reasons. The company is paying off $6.5 billion in debt, along with additional cash saved, which it can use for returns. Overall, the company will be able to maintain its dividend, and repurchase shares, while saving to repurchase preferred equity.

Occidental Petroleum stock (NYSE: OXY) has faced a challenging period. The stock has decreased approximately 20% in the last year, while the S&P 500 has risen 18%.

Occidental Petroleum (OXY -0.20%), commonly known as Oxy, fell 7.3% on Oct. 2 in response to news that it is selling its petrochemical division, OxyChem, to Warren Buffett-led Berkshire Hathaway (BRK.A 0.34%) (BRK.B 0.42%) for $9.7 billion. Here's why the deal is better for Berkshire than Oxy, and if the energy stock is worth buying on the dip.